Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-National, Randomized, Double-Blind, Crossover Study to Evaluate the Efficacy and Safety of Gadopiclenol-enhanced MRA Compared to Gadoterate Meglumine-enhanced MRA in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

NCT07348640 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT07348640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07348640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-National, Randomized, Double-Blind, Crossover Study to Evaluate the Efficacy and Safety of Gadopiclenol-enhanced MRA Compared to Gadoterate Meglumine-enhanced MRA in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease
Lead sponsor
Guerbet
Phase
Phase 3
Overall status
Recruiting
Start date
July 28, 2026
Completion date
December 31, 2027
Enrollment
315 (estimated)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

steno-occlusive disease